 Leukemia, Erythroblastic, Acute
"Leukemia, Erythroblastic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Descriptor ID |
D004915
|
| MeSH Number(s) |
C04.557.337.539.550.325 C15.378.190.636.276
|
| Concept/Terms |
Leukemia, Erythroblastic, Acute- Leukemia, Erythroblastic, Acute
- Myeloid Leukemia, Acute, M6
- Erythroleukemia
- Erythroleukemias
- Di Guglielmo's Disease
- Di Guglielmos Disease
- Disease, Di Guglielmo's
- Erythremic Myelosis
- Erythremic Myeloses
- Myeloses, Erythremic
- Myelosis, Erythremic
- Erythroblastic Leukemia, Acute
- Acute Erythroblastic Leukemia
- Acute Erythroblastic Leukemias
- Erythroblastic Leukemias, Acute
- Leukemia, Acute Erythroblastic
- Leukemias, Acute Erythroblastic
- Leukemia, Myeloid, Acute, M6
- Di Guglielmo Disease
- Disease, Di Guglielmo
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Erythroblastic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Erythroblastic, Acute".
This graph shows the total number of publications written about "Leukemia, Erythroblastic, Acute" by people in this website by year, and whether "Leukemia, Erythroblastic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 0 | 1 | 1 | | 1988 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 | | 1991 | 0 | 2 | 2 | | 1992 | 1 | 1 | 2 | | 2002 | 1 | 0 | 1 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Leukemia, Erythroblastic, Acute" by people in Profiles.
-
Margolskee E, Mikita G, Rea B, Bagg A, Zuo Z, Sun Y, Goswami M, Wang SA, Oak J, Arber DA, Allen MB, George TI, Rogers HJ, Hsi E, Hasserjian RP, Orazi A. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Mod Pathol. 2018 06; 31(6):873-880.
-
Arber DA. Revisiting erythroleukemia. Curr Opin Hematol. 2017 03; 24(2):146-151.
-
Lapadat R, Tower RL, Tam W, Orazi A, Gheorghe G. Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant. Pediatr Blood Cancer. 2016 May; 63(5):935-7.
-
Huang SC, Cho A, Norton S, Liu ES, Park J, Zhou A, Munagala ID, Ou AC, Yang G, Wickrema A, Tang TK, Benz EJ. Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene. Blood. 2009 Nov 05; 114(19):4233-42.
-
Carbonaro A, Mohanty SK, Huang H, Godley LA, Sohn LL. Cell characterization using a protein-functionalized pore. Lab Chip. 2008 Sep; 8(9):1478-85.
-
Jacobs-Helber SM, Roh KH, Bailey D, Dessypris EN, Ryan JJ, Chen J, Wickrema A, Barber DL, Dent P, Sawyer ST. Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia. Blood. 2003 Jan 15; 101(2):524-31.
-
Sato Y, Bohlander SK, Kobayashi H, Suto Y, Davis EM, Espinosa R, Le Beau MM, Rowley JD. Identification of pericentric inversion 12, inv(12)(p13.1q11), by fluorescence in situ hybridization in a patient with acute myeloid leukemia (AML-M6). Cancer Genet Cytogenet. 1997 Sep; 97(2):157-60.
-
Mutskov V, Angelov D, Pashev I. A preparative method for crosslinking proteins to DNA in nuclei by single-pulse UV laser irradiation. Photochem Photobiol. 1997 Jul; 66(1):42-5.
-
Olopade OI, Thangavelu M, Larson RA, Mick R, Kowal-Vern A, Schumacher HR, Le Beau MM, Vardiman JW, Rowley JD. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood. 1992 Dec 01; 80(11):2873-82.
-
Chong AS, Staren ED, Scuderi P. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma. Cancer Immunol Immunother. 1992; 35(5):335-41.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|